ReviewInvestigational new drugs2025

Rare exon 18 G719A and exon 21 L833V compound EGFR mutations show favorable response to Third-Generation TKI Furmonertinib: A case report and literature review.

Yuejian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.